Anti-CD3E Recombinant Antibody (Visilizumab) (CAT#: TAB-714)

Recombinant humanized (from mouse) antibody expressed in CHO binding to human CD3 receptor. Visilizumab is a humanized monoclonal antibody. It is being investigated for use as an immunosuppressive drug in patients with ulcerative colitis and Crohn’s disease.

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Mouse
  • Derivation
  • Humanized (from mouse)
  • Type
  • IgG2
  • Species Reactivity
  • Human
  • Applications
  • Suitable for use in FuncS, IF, Neut, ELISA, FC, IP, ICC and most other immunological methods.
  • Trade name
  • nuvion
  • CAS
  • 219716-33-3
  • Generic Name
  • visilizumab
  • Related Disease
  • Kidney transplantation
This site uses cookies. Find out more about this site’s cookies. GOT IT!